Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children

Description

The primary objective of this study is to determine if the peri and post operative use of gabapentin in children reduces the need for narcotics after thoracic surgery. We hypothesize that patients who are given gabapentin will need fewer morphine equivalents postoperatively than those who were not given gabapentin

Conditions

Pain, Postoperative

Talk to us

Study Overview

On this page

Study Details

Study overview

The primary objective of this study is to determine if the peri and post operative use of gabapentin in children reduces the need for narcotics after thoracic surgery. We hypothesize that patients who are given gabapentin will need fewer morphine equivalents postoperatively than those who were not given gabapentin

Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children

Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children

Condition
Pain, Postoperative
Intervention / Treatment

-

Contacts and Locations

Sacramento

UC Davis Medical Center, Sacramento, California, United States, 95817

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Age newborn to \< 18 years.
  • 2. Gestational age to be minimum 38 weeks.
  • 3. Undergo cardiac surgery via a sternotomy or thoracotomy.
  • 4. Any Thoracic Surgery
  • 5. Planned noncardiac surgery via a thoracotomy or Video Assisted Thoracotomy (VATS).
  • 6. Surgery will result in an inpatient stay of at least 48 hours.
  • 1. Use of opioids within 30 days prior to study entry.
  • 2. Renal Failure as defined by RIFLE Criteria.
  • 3. History of seizures requiring active treatment.
  • 4. History of chronic pain treated medically.
  • 5. Diagnosis of Autism.
  • 6. Unable to tolerate enteral medications.
  • 7. Hematology/Oncology patients.
  • 8. Parents/legal guardians unable to consent.
  • 9. Participation in another clinical study presently or within the last 30 days
  • 10. Pregnancy
  • 11. Prisoners

Ages Eligible for Study

to 17 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, Davis,

Study Record Dates

2025-12-31